Ramipril recalls: lots, NDC and companies
2 FDA recall records mention Ramipril since November 27, 2024. Each covers specific lots from one company. Check yours below.
Check your Ramipril bottle
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Hikma Pharmaceuticals USA INC.: Ramipril Capsules USP
Hazard (FDA): Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).
FDAMedicines
Lupin Pharmaceuticals Inc.: Ramipril Capsules USP 2.5 mg and 2 more
Hazard (FDA): CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor
FDAMedicines
Atom feed of this list(the 40 newest). Data collected 2026-11-17.